NASDAQ:AMDA - Amedica Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.13 +0.06 (+5.61 %)
(As of 05/23/2018 04:00 PM ET)
Previous Close$1.07
Today's Range$1.03 - $1.24
52-Week Range$1.02 - $6.96
Volume1.52 million shs
Average Volume679,833 shs
Market Capitalization$4.89 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.11

About Amedica (NASDAQ:AMDA)

Amedica logoAmedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. The company offers Valeo silicon nitride spinal fusion devices for use in the cervical and thoracolumbar areas of spine; and a line of non-silicon nitride spinal fixation products to address spinal deformity and degenerative conditions. It also develops femoral heads for use in total hip replacements; and femoral condyle components for use in total knee replacements. The company markets and sells its products to surgeons and hospitals directly, as well as through a network of independent sales distributors. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah.

Receive AMDA News and Ratings via Email

Sign-up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AMDA
CUSIPN/A
Phone801-839-3500

Debt

Debt-to-Equity RatioN/A
Current Ratio0.45
Quick Ratio0.30

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$11.22 million
Price / Sales0.44
Cash FlowN/A
Price / CashN/A
Book Value$1.37 per share
Price / Book0.82

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-9,320,000.00
Net Margins-118.90%
Return on Equity-151.88%
Return on Assets-71.28%

Miscellaneous

Employees33
Outstanding Shares4,360,000

Amedica (NASDAQ:AMDA) Frequently Asked Questions

What is Amedica's stock symbol?

Amedica trades on the NASDAQ under the ticker symbol "AMDA."

When did Amedica's stock split? How did Amedica's stock split work?

Amedica's stock reverse split on Friday, November 10th 2017. The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 9th 2017. An investor that had 100 shares of Amedica stock prior to the reverse split would have 8 shares after the split.

How were Amedica's earnings last quarter?

Amedica (NASDAQ:AMDA) released its quarterly earnings data on Tuesday, November, 21st. The medical equipment provider reported ($0.93) EPS for the quarter, topping analysts' consensus estimates of ($0.94) by $0.01. The medical equipment provider had revenue of $2.96 million for the quarter. Amedica had a negative net margin of 118.90% and a negative return on equity of 151.88%. View Amedica's Earnings History.

When is Amedica's next earnings date?

Amedica is scheduled to release their next quarterly earnings announcement on Tuesday, September, 18th 2018. View Earnings Estimates for Amedica.

Who are some of Amedica's key competitors?

Who are Amedica's key executives?

Amedica's management team includes the folowing people:
  • Dr. B. Sonny Bal, Chairman, Pres & CEO (Age 56)
  • Mr. Bryan J. McEntire, Chief Technology Officer (Age 66)
  • Mr. David O'brien, VP of Operations
  • Mr. Dana Lyons, VP of Sales and Marketing
  • Mr. Clay Smith, Sr. Director of Global Marketing

Has Amedica been receiving favorable news coverage?

Media coverage about AMDA stock has trended somewhat negative this week, according to Accern. The research firm identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Amedica earned a news sentiment score of -0.01 on Accern's scale. They also gave news coverage about the medical equipment provider an impact score of 47.16 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of Amedica?

Shares of AMDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Amedica's stock price today?

One share of AMDA stock can currently be purchased for approximately $1.13.

How big of a company is Amedica?

Amedica has a market capitalization of $4.89 million and generates $11.22 million in revenue each year. Amedica employs 33 workers across the globe.

How can I contact Amedica?

Amedica's mailing address is 1885 WEST 2100 SOUTH, SALT LAKE CITY UT, 84119. The medical equipment provider can be reached via phone at 801-839-3500 or via email at [email protected]


MarketBeat Community Rating for Amedica (AMDA)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  140 (Vote Outperform)
Underperform Votes:  88 (Vote Underperform)
Total Votes:  228
MarketBeat's community ratings are surveys of what our community members think about Amedica and other stocks. Vote "Outperform" if you believe AMDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMDA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Amedica (NASDAQ:AMDA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Amedica in the last 12 months. There are currently 2 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/A$60.00$60.00$60.00
Price Target Upside: N/A2,207.69% upside1,654.39% upside18,361.54% upside

Amedica (NASDAQ:AMDA) Consensus Price Target History

Price Target History for Amedica (NASDAQ:AMDA)

Amedica (NASDAQ:AMDA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/8/2018Maxim GroupReiterated RatingHoldHighView Rating Details
11/27/2017Ladenburg ThalmannDowngradeBuy ➝ NeutralHighView Rating Details
(Data available from 5/23/2016 forward)

Earnings

Amedica (NASDAQ:AMDA) Earnings History and Estimates Chart

Earnings by Quarter for Amedica (NASDAQ:AMDA)

Amedica (NASDAQ:AMDA) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.93 EPS
Next Year EPS Consensus Estimate: $-2.85 EPS

Amedica (NASDAQ AMDA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/18/2018        
11/21/2017Q3 2017($0.94)($0.93)$2.96 millionViewN/AView Earnings Details
9/19/2017Q4 2016($3.12)$3.65 millionViewN/AView Earnings Details
11/10/2016Q316($2.40)($3.60)$4.11 million$3.40 millionViewN/AView Earnings Details
8/11/2016Q216($3.72)($4.80)$4.20 million$4.00 millionViewListenView Earnings Details
5/12/2016Q116($3.00)($3.60)$4.98 million$4.20 millionViewListenView Earnings Details
11/12/2015Q315($0.72)($1.80)$5.00 million$4.80 millionViewN/AView Earnings Details
8/13/2015Q2 2015($19.80)$4.78 millionViewN/AView Earnings Details
5/7/2015Q1 2015($36.00)$4.74 millionViewN/AView Earnings Details
3/5/2015Q4 2014($46.80)$5.15 millionViewN/AView Earnings Details
11/6/2014Q314($6.12)($4.68)$5.95 million$6.00 millionViewN/AView Earnings Details
8/7/2014Q2 2014($192.58)$5.84 millionViewN/AView Earnings Details
5/15/2014Q1 2014($142.19)$5.78 millionViewN/AView Earnings Details
3/31/2014Q413($40.20)$10.44$5.45 million$5.70 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Amedica (NASDAQ:AMDA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Amedica (NASDAQ AMDA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.10%
Institutional Ownership Percentage: 4.90%
Insider Trading History for Amedica (NASDAQ:AMDA)

Amedica (NASDAQ AMDA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2015Ty LombardiVPBuy25,000$0.40$10,000.0051,971View SEC Filing  
12/11/2014David W TruetzelDirectorSell15,000$0.68$10,200.00View SEC Filing  
12/8/2014Jeffrey S WhiteDirectorBuy9,600$0.62$5,952.00View SEC Filing  
2/18/2014David W TruetzelDirectorBuy5,000$5.82$29,100.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Amedica (NASDAQ AMDA) News Headlines

Source:
DateHeadline
Zacks: Amedica (AMDA) Given $4.35 Average Target Price by AnalystsZacks: Amedica (AMDA) Given $4.35 Average Target Price by Analysts
www.americanbankingnews.com - May 15 at 7:14 PM
Amedica Corporation Announces Closing of $15000000 Public Offering of Units Consisting of Convertible Preferred ...Amedica Corporation Announces Closing of $15000000 Public Offering of Units Consisting of Convertible Preferred ...
globenewswire.com - May 14 at 5:25 PM
Amedica Corporation Announces Closing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and WarrantsAmedica Corporation Announces Closing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants
finance.yahoo.com - May 14 at 5:25 PM
Amedica Corporation Announces Pricing of $15000000 Public Offering of Units Consisting of Convertible Preferred ...Amedica Corporation Announces Pricing of $15000000 Public Offering of Units Consisting of Convertible Preferred ...
globenewswire.com - May 10 at 6:05 PM
BRIEF-Amedica Corp Announces Pricing Of $15 Mln Public Offering Of UnitsBRIEF-Amedica Corp Announces Pricing Of $15 Mln Public Offering Of Units
www.reuters.com - May 10 at 6:05 PM
Amedica Corporation Announces Pricing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and WarrantsAmedica Corporation Announces Pricing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants
finance.yahoo.com - May 10 at 6:05 PM
Amedica Shares Nearly Triple on Clinical Trial UpdatesAmedica Shares Nearly Triple on Clinical Trial Updates
www.baystreet.ca - May 9 at 8:12 AM
Amedica up 143% on positive data supporting silicon nitride implantsAmedica up 143% on positive data supporting silicon nitride implants
seekingalpha.com - May 8 at 5:46 PM
US STOCKS ON THE MOVE-Comcast, Fox, Amedica CorpUS STOCKS ON THE MOVE-Comcast, Fox, Amedica Corp
www.nasdaq.com - May 8 at 5:46 PM
Amedica (AMDA) Provides Update on its Clinical StudiesAmedica (AMDA) Provides Update on its Clinical Studies
www.streetinsider.com - May 8 at 5:46 PM
Amedica Corporation Provides Update on its Clinical StudiesAmedica Corporation Provides Update on its Clinical Studies
finance.yahoo.com - May 8 at 5:46 PM
Maxim Group Reiterates Hold Rating for Amedica (AMDA)Maxim Group Reiterates Hold Rating for Amedica (AMDA)
www.americanbankingnews.com - May 8 at 3:28 PM
Amedica (AMDA) Upgraded to "Hold" by ValuEngineAmedica (AMDA) Upgraded to "Hold" by ValuEngine
www.americanbankingnews.com - May 4 at 12:54 AM
Zacks: Amedica (AMDA) Given Average Recommendation of "Hold" by AnalystsZacks: Amedica (AMDA) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - April 30 at 3:22 PM
What Should You Know About Amedica Corporation’s (NASDAQ:AMDA) Growth?What Should You Know About Amedica Corporation’s (NASDAQ:AMDA) Growth?
finance.yahoo.com - April 10 at 5:33 PM
Zacks: Brokerages Set $4.35 Price Target for Amedica Co. (AMDA)Zacks: Brokerages Set $4.35 Price Target for Amedica Co. (AMDA)
www.americanbankingnews.com - March 31 at 3:18 PM
Does Amedica Corporation’s (NASDAQ:AMDA) Latest Financial Perfomance Look Strong?Does Amedica Corporation’s (NASDAQ:AMDA) Latest Financial Perfomance Look Strong?
finance.yahoo.com - March 26 at 5:24 PM
Amedica (AMDA) Lifted to "Sell" at ValuEngineAmedica (AMDA) Lifted to "Sell" at ValuEngine
www.americanbankingnews.com - March 25 at 9:16 PM
Analyzing Amedica (AMDA) and Zimmer Biomet (ZBH)Analyzing Amedica (AMDA) and Zimmer Biomet (ZBH)
www.americanbankingnews.com - March 21 at 4:32 PM
Amedica (AMDA) Granted Extension by NASDAQ to Regain ... - StreetInsider.comAmedica (AMDA) Granted Extension by NASDAQ to Regain ... - StreetInsider.com
www.streetinsider.com - March 16 at 8:13 AM
Amedica Granted Extension by NASDAQ to Regain Compliance with NASDAQ Listing RuleAmedica Granted Extension by NASDAQ to Regain Compliance with NASDAQ Listing Rule
finance.yahoo.com - March 15 at 6:18 PM
Financial Comparison: Obalon Therapeutics (OBLN) vs. Amedica (AMDA)Financial Comparison: Obalon Therapeutics (OBLN) vs. Amedica (AMDA)
www.americanbankingnews.com - March 12 at 9:15 PM
Mid-Day Market Update: Dow Falls Over 100 Points; Amedica ... - NasdaqMid-Day Market Update: Dow Falls Over 100 Points; Amedica ... - Nasdaq
www.nasdaq.com - March 8 at 8:16 AM
Amedica (AMDA) Announces FDA Clearance of Valeo C+CSC with ... - StreetInsider.comAmedica (AMDA) Announces FDA Clearance of Valeo C+CSC with ... - StreetInsider.com
www.streetinsider.com - March 7 at 8:11 AM
Amedica announces FDA Clearance of the Valeo C+CSC with Lumen Interbody Fusion DeviceAmedica announces FDA Clearance of the Valeo C+CSC with Lumen Interbody Fusion Device
finance.yahoo.com - March 6 at 5:44 PM
Amedicas stock rockets off record low after FDA clearance of spinal fusion implant deviceAmedica's stock rockets off record low after FDA clearance of spinal fusion implant device
finance.yahoo.com - March 6 at 5:44 PM
Amedica (AMDA) & Orthopediatrics (KIDS) Critical SurveyAmedica (AMDA) & Orthopediatrics (KIDS) Critical Survey
www.americanbankingnews.com - March 4 at 11:26 AM
AMEDICA Announces Participation in Australian Spine Conference - GlobeNewswire (press release)AMEDICA Announces Participation in Australian Spine Conference - GlobeNewswire (press release)
globenewswire.com - February 28 at 8:12 AM
AMEDICA Announces Participation in Australian Spine ConferenceAMEDICA Announces Participation in Australian Spine Conference
finance.yahoo.com - February 27 at 5:59 PM
Second Sight Medical Products (EYES) and Amedica (AMDA) Critical SurveySecond Sight Medical Products (EYES) and Amedica (AMDA) Critical Survey
www.americanbankingnews.com - February 9 at 1:14 AM
Smith & Nephew (SNN) & Amedica (AMDA) Head to Head ContrastSmith & Nephew (SNN) & Amedica (AMDA) Head to Head Contrast
www.americanbankingnews.com - January 28 at 3:18 PM
AMEDICA PROVIDES BUSINESS UPDATEAMEDICA PROVIDES BUSINESS UPDATE
finance.yahoo.com - January 25 at 3:40 PM
Maxim Group Reaffirms Hold Rating for Amedica (AMDA)Maxim Group Reaffirms Hold Rating for Amedica (AMDA)
www.americanbankingnews.com - January 24 at 11:18 PM
Financial Analysis: Glaukos (GKOS) versus Amedica (AMDA)Financial Analysis: Glaukos (GKOS) versus Amedica (AMDA)
www.americanbankingnews.com - January 17 at 1:28 AM
Amedica (AMDA) versus The Competition Critical SurveyAmedica (AMDA) versus The Competition Critical Survey
www.americanbankingnews.com - January 6 at 7:14 PM
Comparing Amedica (AMDA) and Its RivalsComparing Amedica (AMDA) and Its Rivals
www.americanbankingnews.com - January 5 at 11:08 PM
Critical Contrast: Amedica (AMDA) & Its PeersCritical Contrast: Amedica (AMDA) & Its Peers
www.americanbankingnews.com - January 3 at 9:44 PM
Critical Contrast: Amedica (AMDA) vs. Its RivalsCritical Contrast: Amedica (AMDA) vs. Its Rivals
www.americanbankingnews.com - December 28 at 3:44 PM
Amedica (AMDA) & Its Competitors Critical SurveyAmedica (AMDA) & Its Competitors Critical Survey
www.americanbankingnews.com - December 24 at 5:34 PM
Zacks: Analysts Set $4.35 Target Price for Amedica Co. (AMDA)Zacks: Analysts Set $4.35 Target Price for Amedica Co. (AMDA)
www.americanbankingnews.com - December 18 at 3:52 PM
Contrasting Amedica (AMDA) & Its PeersContrasting Amedica (AMDA) & Its Peers
www.americanbankingnews.com - December 18 at 3:10 PM
Stryker (SYK) versus Amedica (AMDA) Financial ComparisonStryker (SYK) versus Amedica (AMDA) Financial Comparison
www.americanbankingnews.com - December 18 at 11:50 AM
Head to Head Comparison: Amedica (AMDA) & Its PeersHead to Head Comparison: Amedica (AMDA) & Its Peers
www.americanbankingnews.com - December 16 at 3:26 AM
ETFs with exposure to Amedica Corp. : December 15, 2017ETFs with exposure to Amedica Corp. : December 15, 2017
finance.yahoo.com - December 15 at 3:44 PM
Amedica (AMDA) vs. Stryker (SYK) Head to Head SurveyAmedica (AMDA) vs. Stryker (SYK) Head to Head Survey
www.americanbankingnews.com - December 13 at 11:16 AM
Head to Head Comparison: Amedica (AMDA) vs. Its PeersHead to Head Comparison: Amedica (AMDA) vs. Its Peers
www.americanbankingnews.com - December 12 at 5:16 PM
Amedica (AMDA) vs. The Competition Head to Head AnalysisAmedica (AMDA) vs. The Competition Head to Head Analysis
www.americanbankingnews.com - December 9 at 9:36 AM
Contrasting Amedica (AMDA) and Its RivalsContrasting Amedica (AMDA) and Its Rivals
www.americanbankingnews.com - December 9 at 9:36 AM
ETFs with exposure to Amedica Corp. : December 5, 2017ETFs with exposure to Amedica Corp. : December 5, 2017
finance.yahoo.com - December 5 at 1:01 PM
Amedica (AMDA) Rating Lowered to Sell at ValuEngineAmedica (AMDA) Rating Lowered to Sell at ValuEngine
www.americanbankingnews.com - December 3 at 11:40 PM

SEC Filings

Amedica (NASDAQ:AMDA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Amedica (NASDAQ:AMDA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Amedica (NASDAQ AMDA) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.